Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin in Schizophrenia
NCT00575666Phase 4Completed
- Sponsor
- University of Massachusetts
- Start
- Dec 2007
- Primary completion
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Generex Oral-lyn in schizophrenia, schizoaffective disorder, sponsored by University of Massachusetts. Started Dec 2007; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00575666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575666.